Rydex S&P MidCap 400 Pure Growth H
RYBHX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Rockville, MD 20850 Rockville MD United States of America 20850
- IPO Date
- Feb 20, 2004
- CIK
- 0000899148
- Website
- guggenheiminvestments.com
- Similar Companies
- Business
- Rydex S&P MidCap 400 Pure Growth Fund Class H (RYBHX) is an open-end mutual fund that seeks to replicate the daily performance of the S&P MidCap 400 Pure Growth Index, focusing on mid-cap growth securities; it invests at least 80% of its net assets, plus borrowings for investment purposes, in securities comprising the underlying index or derivatives providing similar exposure, with daily rebalancing to maintain alignment. The fund offers Class H shares with a net expense ratio of 1.52%, no front-end or deferred loads, a minimum initial investment of $2,500, and annual distributions if applicable; it emphasizes pure growth stocks selected for high growth scores within the S&P MidCap 400 universe, spanning sectors such as industrials (28%), healthcare (17%), consumer cyclical (15%), technology (13%), and financial services (11%), with top holdings including Roivant Sciences Ltd, Carpenter Technology Corp, Hims & Hers Health Inc, Comfort Systems USA Inc, and Globus Medical Inc. Managed by a team at Security Investors, LLC, including Michael Byrum (since inception), Brendan Cain, Spencer Crane, and Scott Miller (since July 2022), the fund targets U.S. investors in the mid-cap growth category and is distributed by Guggenheim Funds Distributors, LLC, under the Rydex Funds family of Guggenheim Investments. Launched on February 20, 2004, and domiciled in the United States with administrative operations in Rockville, Maryland, it had total net assets of approximately $26.3 million as of recent data, primarily U.S.-focused (94% allocation) with minor non-U.S. exposure. Recent developments include a December 16, 2024, prospectus supplement from Rydex Series Funds, manager team stability since mid-2022, and ongoing portfolio oversight amid Guggenheim Investments' strategic focus on core Rydex Strategies following the 2024 divestiture of certain actively managed equity funds to New Age Alpha.